Column Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Column Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$40.6K	Hold	700	–	–	0.01%	345
2023 Q2	$44.8K	Hold	700	–	–	0.01%	338
2023 Q1	$48.5K	Hold	700	–	–	0.01%	325
2022 Q4	$50.4K	Hold	700	–	–	0.01%	296
2022 Q3	$50K	Hold	700	–	–	0.01%	272
2022 Q2	$54K	Hold	700	–	–	0.01%	266
2022 Q1	$51K	Buy	700 +639	+1,048%	+$42.9K	0.01%	284
2021 Q4	$4K	Sell	61 -442	-88%	-$25.9K	﹤0.01%	596
2021 Q3	$30K	Sell	503 -21	-4%	-$1.38K	0.01%	340
2021 Q2	$35K	Sell	524 -155	-23%	-$10.1K	0.01%	325
2021 Q1	$43K	Buy	679 +145	+27%	+$9.02K	0.01%	292
2020 Q4	$33K	Hold	534	–	–	0.01%	324
2020 Q3	$32K	Sell	534 -61	-10%	-$3.67K	0.01%	307
2020 Q2	$34K	Buy	595 +179	+43%	+$10.7K	0.01%	301
2020 Q1	$23K	Sell	416 -298	-42%	-$18.2K	0.01%	288
2019 Q4	$45K	Buy	+714	New	+$40.9K	0.02%	255

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Column Capital Advisors's BMY Position: Q3 2023 in Review

Column Capital Advisors held its Bristol-Myers Squibb (BMY) position steady in Q3 2023 at 700 shares worth $40.6K. The position accounts for 0.01% of the portfolio, ranked #345.

Column Capital Advisors first reported a position in BMY in Q4 2019 and has held it in 16 quarters since. The position peaked at $54K in Q2 2022. 2,389 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Column Capital Advisors held 700 shares of Bristol-Myers Squibb worth $40.6K as of Q3 2023.
Column Capital Advisors left its Bristol-Myers Squibb share count unchanged in Q3 2023.
Bristol-Myers Squibb made up 0.01% of Column Capital Advisors's portfolio in Q3 2023, its #345 holding.
Column Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 16 quarters since.
Column Capital Advisors's Bristol-Myers Squibb position peaked at $54K in Q2 2022.
2,389 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.